Athira Pharma, Inc. (ATHA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.3200 |
| Open | 3.3600 |
| Bid | 3.2600 x 100 |
| Ask | 3.3300 x 400 |
| Day's range | 3.2500 - 3.3750 |
| 52-week range | 1.3300 - 4.2980 |
| Volume | |
| Avg. volume | 143,891 |
| Market cap | 126.868M |
| Beta (5Y monthly) | 2.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up
Athira (ATHA) completes dosing the last patient in the phase II/III LIFT-AD study on fosgonimeton for treating people with mild-to-moderate Alzheimer's disease. Stock gains.
- Simply Wall St.
retail investors who own 35% along with institutions invested in Athira Pharma, Inc. (NASDAQ:ATHA) saw increase in their holdings value last week
Key Insights The considerable ownership by retail investors in Athira Pharma indicates that they collectively have a...
- Simply Wall St.
We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
© 2024 Yahoo. All rights reserved.